You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 415 Toripalimab plus nab-paclitaxel and carboplatin as neoadjuvant therapy for patients with esophageal squamous cell carcinoma at clinical stage T2-T4/N0-N2/M0: a single-arm, single-center clinical study

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
415 Toripalimab plus nab-paclitaxel and carboplatin as neoadjuvant therapy for patients with esophageal squamous cell carcinoma at clinical stage T2-T4/N0-N2/M0: a single-arm, single-center clinical study

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020121012
Dec 20205208
Jan 20213206
Feb 20214208
Mar 202141011
Apr 20212005
May 20218022
Jun 2021007
Jul 2021007
Aug 20211013
Sep 20210011
Oct 202144042
Nov 202142024
Dec 20215406
Jan 20222204
Feb 20222603
Mar 20223607
Apr 20225008
May 20224105
Jun 20223206
Jul 20222003
Aug 20221904
Sep 20221907
Oct 20221402
Nov 20223305
Dec 20222204
Jan 20231001
Feb 202340013
Mar 20232203
Apr 20231402
May 2023802
Jun 2023801
Jul 20231206
Aug 20231605
Sep 20231207
Oct 20231606
Nov 20232808
Dec 20233206
Jan 20241000
Feb 20243402
Mar 20243004
Apr 20243204
May 20244003
Jun 20242601
Jul 20241001
Aug 20241802
Sep 20242601
Oct 2024805
Nov 20242002
Dec 20241205
Jan 2025808
Feb 2025206
Mar 2025002
Apr 2025007
May 2025006
Jun 2025105
Total12860364